Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Wake Forest University Health Sciences
Wake Forest University Health Sciences
University of Alabama at Birmingham
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Hackensack Meridian Health
Hackensack Meridian Health
The Methodist Hospital Research Institute
Hackensack Meridian Health
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Hackensack Meridian Health
Hoosier Cancer Research Network
Ciusss de L'Est de l'Ăle de MontrĂ©al
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Mayo Clinic
Dana-Farber Cancer Institute
Hackensack Meridian Health
M.D. Anderson Cancer Center
Essen Biotech
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Chicago
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Seoul National University Hospital
Memorial Sloan Kettering Cancer Center
University of Southern California
Yale University
Mayo Clinic
Institute of Hematology & Blood Diseases Hospital, China
Mayo Clinic
City of Hope Medical Center
Oslo University Hospital
Mayo Clinic
Essen Biotech
City of Hope Medical Center
M.D. Anderson Cancer Center
Tianjin Medical University General Hospital
University of Maryland, Baltimore
UniversitÀtsklinikum Hamburg-Eppendorf
Zhongnan Hospital
Wake Forest University Health Sciences
Xuzhou Medical University
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Shenzhen University General Hospital
Columbia University
Mayo Clinic